ARS Pharmaceuticals (SPRY) EPS (Basic) (2020 - 2026)
ARS Pharmaceuticals (SPRY) posted EPS (Basic) of -$0.97 for Q1 2026, down 118.82% sequentially from -$0.44 in Q4 2025, and down 153.74% YoY from $1.8 in Q1 2025.
ARS Pharmaceuticals (SPRY) EPS (Basic) (2020 - 2026) Analysis & Trends
ARS Pharmaceuticals has reported EPS (Basic) for 7 years, with the latest figure at -$0.97 in Q1 2026.
- Quarterly EPS (Basic) fell 153.74% year-over-year to -$0.97 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.78 (down 120.2% YoY) and the FY2025 annual result came in at -$1.74, down 2206.35% from the prior year.
- EPS (Basic) slipped to -$0.97 in Q1 2026 per SPRY's latest filing, from -$0.44 in the prior quarter.
- Over five years, EPS (Basic) peaked at $0.49 in Q4 2024 and troughed at -$418.21 in Q1 2023.
- A 5-year average of -$58.36 and a median of -$0.7 in 2024 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2023 and 2024: EPS (Basic) tumbled 126507.86% in 2023, then soared 563.49% in 2024.
- Over 5 years, EPS (Basic) stood at -$0.38 in 2022, then surged by 72.23% to -$0.11 in 2023, then jumped by 563.49% to $0.49 in 2024, then tumbled by 190.56% to -$0.44 in 2025, then slumped by 118.82% to -$0.97 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.97, -$0.44, and -$1.14 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | ARS Pharmaceuticals | 561.88 Mn | 418.03 Mn | - | -0.97 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.97 |
| Mar 31, 2026 | -0.97 |
| Dec 31, 2025 | -0.44 |
| Sep 30, 2025 | -1.14 |
| Jun 30, 2025 | -2.26 |
| Mar 31, 2025 | -0.38 |
| Dec 31, 2024 | 0.49 |
| Sep 30, 2024 | -1.60 |
| Jun 30, 2024 | -0.70 |
| Mar 31, 2024 | -0.94 |
| Dec 31, 2023 | -0.11 |
| Sep 30, 2023 | -161.76 |
| Jun 30, 2023 | -402.49 |
| Mar 31, 2023 | -418.21 |
| Dec 31, 2022 | -0.38 |
| Sep 30, 2022 | -0.43 |
| Jun 30, 2022 | -0.39 |
| Mar 31, 2022 | -0.33 |
| Dec 31, 2021 | 1.35 |
| Sep 30, 2021 | -1.27 |